Background: Paradoxical diplopia occurs when binocular visual cerebral cortex projection of diplopic images (the "subjective angle") is not commensurate and identical with angle or direction of strabismus (the "objective angle"). Its presence infers anomalous retinal correspondence and is manifest as heteronymous or crossed diplopia in esotropia and homonymous or uncrossed diplopia in exotropia. When treated, the prognosis for achieving fusion is poor, while the risk for intractable diplopia is reputedly high. We report a patient with paradoxical diplopia that resolved (and some binocular fusion developed) following botulinum toxin injections and prism therapy.
Research Design: Case report.
Case Report: A 25 year old man was evaluated for an exotropia. At age 4 years, he had acquired an esotropia due to a traumatic lateral rectus palsy. The esotropia resolved over 3 years. At age 14 years, he developed a consecutive exotropia. The exotropia was eventually treated surgically. There remained a residual exotropia following surgery, and he experienced paradoxical diplopia and projected it homonymously on all sensory tests as if he was esotropic. Treatment with botulinum toxin injections to both lateral rectus muscles along with a small prismatic correction in spectacles eliminated the exotropia and paradoxical diplopia, permitting some binocular fusion.
Conclusion: Botulinum toxin injection and prism therapy can be effective in eradicating paradoxical diplopia.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Isolated Ischemic Inferior Rectus Paresis Related to Patent Foramen Ovale.
Neuroophthalmology
January 2024
Department of Hematology, University Hospital 12 de Octubre, Madrid, Spain.
Isolated paresis of the inferior rectus muscle (IRM) represents a rare occurrence. This case report involves a young adult male who, abruptly during a Valsalva maneuver, encountered acute vertical diplopia due to right IRM paresis, resolving spontaneously within a few hours. The patient presented without identifiable risk factors, and magnetic resonance imaging revealed a minor left thalamic ischemic lesion.
View Article and Find Full Text PDFCOVID-19 infection has been associated with paradoxical thromboembolism through a patent foramen ovale (PFO) and ischaemic stroke. Such events have not been reported after COVID-19 vaccination. The aim of the present study was to investigate PFO-associated stroke during the mass COVID-19 vaccination in Slovenia.
View Article and Find Full Text PDFParadoxical embolism is an uncommon phenomenon, accounting for only 2% of all cases of systemic arterial embolism. This condition suggests the presence of a patent foramen ovale, present in 20% - 25% of the adult population. The authors report the case of a 63-year-old male patient with a history of lung adenocarcinoma and hereditary thrombophilia admitted to hospital with acute onset of dyspnea, diplopia, confusion and decreased motor strength of the right limbs.
View Article and Find Full Text PDFClinical findings and surgical outcomes of patients with traumatic isolated inferior rectus muscle paresis.
J AAPOS
December 2019
Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran. Electronic address:
Purpose: To evaluate clinical findings and surgical outcomes of patients with traumatic isolated inferior rectus muscle paresis.
Methods: The medical records of patients with traumatic isolated inferior rectus paresis who underwent strabismus surgery at Farabi Eye Hospital between 2011 and 2018 were reviewed retrospectively. Clinical features, type of surgery, and surgical outcomes were extracted from the record for analysis.
Paradoxical Reaction in a Patient with Co-Occurring Tuberculous Meningitis and Pott's Disease.
Am J Case Rep
June 2018
Department of Internal Medicine, Section of Infectious Disease, Yale University School of Medicine, New Haven, CT, USA.
BACKGROUND Paradoxical reactions to tuberculosis (TB) are clinical or radiological worsening of prior tuberculous lesions or the development of new lesions upon treatment with appropriate anti-tuberculosis therapy (ATT). This phenomenon has been described in both HIV-seropositive and HIV-seronegative patients. Although historically estimated to occur in 6-30% of HIV-seronegative patients with TB, the phenomenon is often under-recognized in the current era, particularly in countries of low TB prevalence.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!